122 related articles for article (PubMed ID: 11872032)
1. E-cadherin and beta-catenin are down-regulated in prostatic bone metastases.
Bryden AA; Hoyland JA; Freemont AJ; Clarke NW; Schembri Wismayer D; George NJ
BJU Int; 2002 Mar; 89(4):400-3. PubMed ID: 11872032
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin and beta-catenin loss of expression related to bone metastasis in prostate cancer.
Pontes J; Srougi M; Borra PM; Dall' Oglio MF; Ribeiro-Filho LA; Leite KR
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):179-84. PubMed ID: 18685493
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of E-cadherin and beta-catenin proteins in metastatic prostate cancer cells in bone.
Saha B; Arase A; Imam SS; Tsao-Wei D; Naritoku WY; Groshen S; Jones LW; Imam SA
Prostate; 2008 Jan; 68(1):78-84. PubMed ID: 18008331
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.
Davidson B; Berner A; Nesland JM; Risberg B; Berner HS; Tropè CG; Kristensen GB; Bryne M; Ann Florenes V
J Pathol; 2000 Dec; 192(4):460-9. PubMed ID: 11113863
[TBL] [Abstract][Full Text] [Related]
5. Low E-cadherin and beta-catenin expression correlates with increased spontaneous and artificial lung metastases of murine carcinomas.
Akimoto T; Kawabe S; Grothey A; Milas L
Clin Exp Metastasis; 1999 Mar; 17(2):171-6. PubMed ID: 10411110
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical expression of E-cadherin in prostatic bone metastases.
Bryden AA; Freemont AJ; Clarke NW; George NJ
BJU Int; 1999 Dec; 84(9):1032-4. PubMed ID: 10571629
[TBL] [Abstract][Full Text] [Related]
7. Expression of the E-cadherin-catenin complex in lung neuroendocrine tumours.
Clavel CE; Nollet F; Berx G; Tejpar S; Nawrocki-Raby B; Kaplan HH; van Roy FM; Birembaut PL
J Pathol; 2001 May; 194(1):20-6. PubMed ID: 11329137
[TBL] [Abstract][Full Text] [Related]
8. Expression of cadherins and catenins in paired tumor and non-neoplastic primary prostate cultures and corresponding prostatectomy specimens.
Wang J; Krill D; Torbenson M; Wang Q; Bisceglia M; Stoner J; Thomas A; DeFlavia P; Dhir R; Becich MJ
Urol Res; 2000 Oct; 28(5):308-15. PubMed ID: 11127708
[TBL] [Abstract][Full Text] [Related]
9. [Detection of gene promoter methylation and mRNA, protein expression levels of E-cadherin in nasopharyngeal carcinoma].
Li Z; Lin SX; Liang YJ
Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):25-30. PubMed ID: 12760799
[TBL] [Abstract][Full Text] [Related]
10. Immunohistological analysis of E-cadherin, alpha-, beta- and gamma-catenin expression in colorectal cancer: implications for cell adhesion and signaling.
Ghadimi BM; Behrens J; Hoffmann I; Haensch W; Birchmeier W; Schlag PM
Eur J Cancer; 1999 Jan; 35(1):60-5. PubMed ID: 10211089
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinoma.
Ramasami S; Kerr KM; Chapman AD; King G; Cockburn JS; Jeffrey RR
J Pathol; 2000 Dec; 192(4):427-32. PubMed ID: 11113858
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.
Bukholm IK; Nesland JM; Kåresen R; Jacobsen U; Børresen-Dale AL
J Pathol; 1998 Jul; 185(3):262-6. PubMed ID: 9771479
[TBL] [Abstract][Full Text] [Related]
13. Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers.
Davies BR; Worsley SD; Ponder BA
Histopathology; 1998 Jan; 32(1):69-80. PubMed ID: 9522220
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic redistribution of E-cadherin-catenin adhesion complex is associated with down-regulated tyrosine phosphorylation of E-cadherin in human bronchopulmonary carcinomas.
Nawrocki B; Polette M; Van Hengel J; Tournier JM; Van Roy F; Birembault P
Am J Pathol; 1998 Nov; 153(5):1521-30. PubMed ID: 9811344
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.
Chen G; Shukeir N; Potti A; Sircar K; Aprikian A; Goltzman D; Rabbani SA
Cancer; 2004 Sep; 101(6):1345-56. PubMed ID: 15316903
[TBL] [Abstract][Full Text] [Related]
16. Changes in cadherin-catenin complexes in the progression of human bladder carcinoma.
Giroldi LA; Bringuier PP; Shimazui T; Jansen K; Schalken JA
Int J Cancer; 1999 Jul; 82(1):70-6. PubMed ID: 10360823
[TBL] [Abstract][Full Text] [Related]
17. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
Yoshida R; Kimura N; Harada Y; Ohuchi N
Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
[TBL] [Abstract][Full Text] [Related]
18. Biological relevance of E-cadherin-catenin complex proteins in primary epithelial ovarian tumours.
Faleiro-Rodrigues C; Macedo-Pinto IM; Maia SS; Vieira RH; Lopes CS
Gynecol Obstet Invest; 2005; 60(2):75-83. PubMed ID: 15785075
[TBL] [Abstract][Full Text] [Related]
19. Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis.
Zheng Z; Pan J; Chu B; Wong YC; Cheung AL; Tsao SW
Hum Pathol; 1999 Apr; 30(4):458-66. PubMed ID: 10208469
[TBL] [Abstract][Full Text] [Related]
20. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K
Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
